Industries > Pharma > Enteric Soft Gel Capsules Market Report 2021-2031
Enteric Soft Gel Capsules Market Report 2021-2031
By Product Type (Gelatin Enteric Soft Gel Capsules, and Non-Gelatin Enteric Soft Gel Capsules), By Application (Pharmaceuticals, and Medical and Health Supplements), By Patient Demographics (Geriatric, Adult, and Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Leading Regional/ Country market analysis
Enteric Soft Gel Capsules Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Enteric Soft Gel Capsules is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 300+ page report provides 330+ tables and 300+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Enteric Soft Gel Capsules Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Enteric Soft Gel Capsules Market By Product Type
• Gelatin Enteric Soft Gel Capsules
• Non-Gelatin Enteric Soft Gel Capsules
• Revenue and growth forecasts from 2021 to 2031 for the Global Enteric Soft Gel Capsules Market By Application
• Pharmaceuticals
• Medical and Health Supplements
• Revenue and growth forecasts from 2021 to 2031 for the Global Enteric Soft Gel Capsules Market By Age Group
• Geriatric
• Adult
• Pediatric
• Revenue and growth forecasts from 2021 to 2031 for the Global Enteric Soft Gel Capsules Market By End User
• Hospitals
• Homecare
• Specialty Clinics
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Enteric Soft Gel Capsules Market By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Enteric Soft Gel Capsules Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Enteric Soft Gel Capsules Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Enteric Soft Gel Capsules Market report helps you
In summary, our 300+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Enteric Soft Gel Capsules Market, with forecasts for Get our report today Enteric Soft Gel Capsules Market Forecast 2021-2031: By Product Type, Drug Type, Application, Patient Demographics, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Enteric Soft Gel Capsules market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Enteric Soft Gel Capsules Market. Some of the company’s profiled in this report include
• BASF SE
• Catalent, Inc.
• Colorcon, Inc.
• Fuji Capsules Co., Ltd.
• Procaps
• NOW Foods Inc.
• Thermo Fisher Scientific, Inc. (Patheon)
• Sirio Pharma Co., LTD
• Super Spectrim
• Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.)
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Enteric Soft Gel Capsules Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Enteric Soft Gel Capsules Market Report 2021-2031: By Product Type (Gelatin Enteric Soft Gel Capsules, and Non-Gelatin Enteric Soft Gel Capsules), By Application (Pharmaceuticals, and Medical and Health Supplements), By Patient Demographics (Geriatric, Adult, and Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Leading Regional/ Country market analysis.. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Enteric Soft Gel Capsules Market
2.1. Enteric Soft Gel Capsules Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Application Submarkets Definitions
3. Enteric Soft Gel Capsules Market Overview
3.1. Global Enteric Soft Gel Capsules Market Size and Forecast By Region
3.2. Global Enteric Soft Gel Capsules Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing geriatric population around the world
3.3.1.2. Growing demand for Omega-3 supplements around the world
3.3.1.3. Surging investment in enteric soft gel capsules
3.3.1.4. Increasing research and developed activates
3.3.2. Market Restraints
3.3.2.1. High cost of development
3.3.2.2. Unavailability of reimbursement
3.3.2.3. Stringent regulation associated with product development
3.3.3. Opportunities
3.3.3.1. Growing awareness regarding consumption of preventive medicines
3.3.3.2. Growing demand of enteric soft gel capsules in developing geographies
3.3.4. Challenges
3.3.4.1. Availability of alternatives
3.3.4.2. Side effects associated with enteric soft gel capsules
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Gelatin Enteric Soft Gel Capsules
4.1.1.1. Gelatin Enteric Soft Gel Capsules market size and forecast, 2021-2031 (USD Million)
4.1.2. Non-Gelatin Enteric Soft Gel Capsules
4.1.2.1. Non-Gelatin Enteric Soft Gel Capsules market size and forecast, 2021-2031 (USD Million)
5. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Pharmaceuticals
5.1.1.1. Pharmaceuticals market size and forecast, 2021-2031 (USD Million)
5.1.2. Medical and Health Supplements
5.1.2.1. Medical and Health Supplements market size and forecast, 2021-2031 (USD Million)
6. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By Age Group (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Geriatric
6.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
6.1.2. Adult Patient
6.1.2.1. Adult Patient market size and forecast, 2021-2031 (USD Million)
6.1.3. Pediatric
6.1.3.1. Pediatric Market size and forecast, 2021-2031 (USD Million)
7. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Hospitals
7.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
7.1.2. Homecare
7.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
7.1.3. Specialty Clinics
7.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.4. Others
7.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospital Pharmacies
8.1.1.1. Hospital Pharmacies market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Pharmacies
8.1.2.1. Retail Pharmacies market size and forecast, 2021-2031 (USD Million)
8.1.3. Online Pharmacies
8.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
9. North America Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Enteric Soft Gel Capsules Market Size and Forecast By Product Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Enteric Soft Gel Capsules Market Size and Forecast By Application
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Enteric Soft Gel Capsules Market Size and Forecast By Age Group
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Enteric Soft Gel Capsules Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Enteric Soft Gel Capsules Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Enteric Soft Gel Capsules Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Enteric Soft Gel Capsules Market Size and Forecast By Product Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Enteric Soft Gel Capsules Market Size and Forecast By Application
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Enteric Soft Gel Capsules Market Size and Forecast By Age Group
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Enteric Soft Gel Capsules Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Enteric Soft Gel Capsules Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Enteric Soft Gel Capsules Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Enteric Soft Gel Capsules Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Enteric Soft Gel Capsules Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By Product Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By Application
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By Age Group
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Enteric Soft Gel Capsules Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Enteric Soft Gel Capsules Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Enteric Soft Gel Capsules Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Enteric Soft Gel Capsules Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Enteric Soft Gel Capsules Market Size and Forecast By Product Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Enteric Soft Gel Capsules Market Size and Forecast By Application
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Enteric Soft Gel Capsules Market Size and Forecast By Age Group
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Enteric Soft Gel Capsules Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
12.7. Brazil Enteric Soft Gel Capsules Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Enteric Soft Gel Capsules Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Enteric Soft Gel Capsules Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Enteric Soft Gel Capsules Market Size and Forecast By Product Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Enteric Soft Gel Capsules Market Size and Forecast By Application
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Enteric Soft Gel Capsules Market Size and Forecast By Age Group
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Enteric Soft Gel Capsules Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Enteric Soft Gel Capsules Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Enteric Soft Gel Capsules Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Enteric Soft Gel Capsules Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Enteric Soft Gel Capsules Market
14.1. BASF SE
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Catalent, Inc.
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Colorcon, Inc.
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Fuji Capsules Co., Ltd.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. Procaps
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. NOW Foods Inc.
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Thermo Fisher Scientific, Inc. (Patheon)
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Sirio Pharma Co., LTD
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Super Spectrim
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.)
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Enteric Soft Gel Capsules Market Drivers & Restraints 2021
Table 7. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 8. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Enteric Soft Gel Capsules Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Enteric Soft Gel Capsules Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 138. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 139. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 140. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 141. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 142. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 143. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 144. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 145. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 146. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 147. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 148. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 149. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 150. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 151. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 152. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 153. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 154. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 155. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 156. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 157. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 158. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 159. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 160. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 161. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 162. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 163. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Leading 10 Enteric Soft Gel Capsules Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 313. BASF SE Profile 2019 (CEO, HQ, Founded, Website)
Table 314. BASF SE Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 315. Catalent, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 316. Catalent, Inc. Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 317. Colorcon, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 318. Colorcon, Inc. Enteric Soft Gel Capsules Product Offering (Segment, Product Offerings)
Table 319. Fuji Capsules Co., Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 320. Fuji Capsules Co., Ltd. Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 321. Procaps Profile 2019 (CEO, HQ, Founded, Website)
Table 322. Procaps Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 323. NOW Foods Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 324. NOW Foods Inc. Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 325. Thermo Fisher Scientific, Inc. (Patheon) Profile 2019 (CEO, HQ, Founded, Website)
Table 326. Thermo Fisher Scientific, Inc. (Patheon) Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 327. Super Spectrim Profile 2019 (CEO, HQ, Founded, Website)
Table 328. Super Spectrim Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 329. Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.) Profile 2019 (CEO, HQ, Founded, Website)
Table 330. Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.) Enteric Soft Gel Capsules Product Offering (Segment, Product Offerings)
Table 331. Sirio Pharma Co., LTD Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 332. Sirio Pharma Co., LTD Enteric Soft Gel Capsules Product Offering (Segment, Product Offerings)
Table 333. Other Companies Involved in the Enteric Soft Gel Capsules Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Enteric Soft Gel Capsules Market Drivers & Restraints 2021
Figure 7. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 8. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Enteric Soft Gel Capsules Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Enteric Soft Gel Capsules Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 98. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 103. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 108. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 113. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 118. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 123. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 138. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 139. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 140. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 141. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 142. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 143. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 144. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 145. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 146. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 147. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 148. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 149. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 150. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 151. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 152. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 153. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 154. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 155. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 156. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 157. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 158. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 159. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 160. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 161. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 162. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 163. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 213. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 214. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 215. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 216. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 217. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 218. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 219. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 220. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 221. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 222. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 223. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 224. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 225. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 226. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 227. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 228. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 229. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 230. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 231. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 232. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 233. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 234. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 235. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 236. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 237. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 238. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 239. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 240. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 241. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 242. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 243. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 244. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 245. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 246. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 247. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 248. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 249. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 250. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 251. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 252. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 253. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 254. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 255. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 256. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 257. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 258. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 259. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 260. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 261. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 262. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 263. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 264. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 265. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 266. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 267. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 268. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 269. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 270. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 271. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 272. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 273. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 274. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 275. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 276. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 277. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 278. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 279. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 280. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 281. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 282. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 283. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 284. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 285. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 286. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 287. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 288. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 289. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 290. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 291. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 292. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 293. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 294. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 295. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 296. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 297. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 298. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 299. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 300. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 301. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 302. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 303. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 304. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 305. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 306. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 307. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 308. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 309. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 310. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 311. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 312. Porter’s Five Force Analysis
Companies Mentioned
1. Abbott Laboratories
2. AbbVie
3. Achaogen
4. Actavis
5. Actelion
6. Affinium Pharmaceutical
7. AiCuris GmbH & Co. KG
8. Alcon
9. Alkem Laboratories
10. Allergan
11. Allied Pharma
12. Apotex
13. APP Pharmaceuticals
14. Aptalis Pharma
15. Aquapharm Biodiscovery
16. Cempra Pharmaceuticals
17. Cipla
18. Claris Lifesciences
19. Cornerstone Biopharma
20. Cornerstone Therapeutics
21. Corona Remedies
22. Eli Lilly
23. Gate Pharma
24. Gilead Sciences
25. GlaxoSmithKline (GSK)
26. Glenmark
27. GlycoVaxyn
28. Hetero
29. Hikma Farmaceutica
30. Hi-Tech Pharma
31. Hospira
32. Macleod Pharmaceuticals
33. Microlabs
34. Nalneva
35. Novartis
36. Novexel
37. Paratek Pharmaceuticals
38. Pfizer
39. Ranbaxy
40. Roche
41. Sagent Pharmaceuticals
42. Sandoz
43. Sanofi
44. Sequella
45. Shanghai MengKe Pharmaceuticals
46. Shionogi
47. SHIONOGI Co., Ltd.
48. Shire
49. Sidmak Labs
50. Solitaire Pharmacia
51. Specialised Therapeutics Australia
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Enteric Soft Gel Capsules Market
2.1. Enteric Soft Gel Capsules Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Application Submarkets Definitions
3. Enteric Soft Gel Capsules Market Overview
3.1. Global Enteric Soft Gel Capsules Market Size and Forecast By Region
3.2. Global Enteric Soft Gel Capsules Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing geriatric population around the world
3.3.1.2. Growing demand for Omega-3 supplements around the world
3.3.1.3. Surging investment in enteric soft gel capsules
3.3.1.4. Increasing research and developed activates
3.3.2. Market Restraints
3.3.2.1. High cost of development
3.3.2.2. Unavailability of reimbursement
3.3.2.3. Stringent regulation associated with product development
3.3.3. Opportunities
3.3.3.1. Growing awareness regarding consumption of preventive medicines
3.3.3.2. Growing demand of enteric soft gel capsules in developing geographies
3.3.4. Challenges
3.3.4.1. Availability of alternatives
3.3.4.2. Side effects associated with enteric soft gel capsules
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Gelatin Enteric Soft Gel Capsules
4.1.1.1. Gelatin Enteric Soft Gel Capsules market size and forecast, 2021-2031 (USD Million)
4.1.2. Non-Gelatin Enteric Soft Gel Capsules
4.1.2.1. Non-Gelatin Enteric Soft Gel Capsules market size and forecast, 2021-2031 (USD Million)
5. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Pharmaceuticals
5.1.1.1. Pharmaceuticals market size and forecast, 2021-2031 (USD Million)
5.1.2. Medical and Health Supplements
5.1.2.1. Medical and Health Supplements market size and forecast, 2021-2031 (USD Million)
6. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By Age Group (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Geriatric
6.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
6.1.2. Adult Patient
6.1.2.1. Adult Patient market size and forecast, 2021-2031 (USD Million)
6.1.3. Pediatric
6.1.3.1. Pediatric Market size and forecast, 2021-2031 (USD Million)
7. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Hospitals
7.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
7.1.2. Homecare
7.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
7.1.3. Specialty Clinics
7.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.4. Others
7.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospital Pharmacies
8.1.1.1. Hospital Pharmacies market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Pharmacies
8.1.2.1. Retail Pharmacies market size and forecast, 2021-2031 (USD Million)
8.1.3. Online Pharmacies
8.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
9. North America Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Enteric Soft Gel Capsules Market Size and Forecast By Product Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Enteric Soft Gel Capsules Market Size and Forecast By Application
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Enteric Soft Gel Capsules Market Size and Forecast By Age Group
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Enteric Soft Gel Capsules Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Enteric Soft Gel Capsules Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Enteric Soft Gel Capsules Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Enteric Soft Gel Capsules Market Size and Forecast By Product Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Enteric Soft Gel Capsules Market Size and Forecast By Application
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Enteric Soft Gel Capsules Market Size and Forecast By Age Group
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Enteric Soft Gel Capsules Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Enteric Soft Gel Capsules Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Enteric Soft Gel Capsules Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Enteric Soft Gel Capsules Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Enteric Soft Gel Capsules Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By Product Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By Application
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By Age Group
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Enteric Soft Gel Capsules Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Enteric Soft Gel Capsules Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Enteric Soft Gel Capsules Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Enteric Soft Gel Capsules Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Enteric Soft Gel Capsules Market Size and Forecast By Product Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Enteric Soft Gel Capsules Market Size and Forecast By Application
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Enteric Soft Gel Capsules Market Size and Forecast By Age Group
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Enteric Soft Gel Capsules Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
12.7. Brazil Enteric Soft Gel Capsules Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Enteric Soft Gel Capsules Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Enteric Soft Gel Capsules Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Enteric Soft Gel Capsules Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Enteric Soft Gel Capsules Market Size and Forecast By Product Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Enteric Soft Gel Capsules Market Size and Forecast By Application
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Enteric Soft Gel Capsules Market Size and Forecast By Age Group
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Enteric Soft Gel Capsules Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Enteric Soft Gel Capsules Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Enteric Soft Gel Capsules Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Enteric Soft Gel Capsules Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Enteric Soft Gel Capsules Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Enteric Soft Gel Capsules Market
14.1. BASF SE
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Catalent, Inc.
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Colorcon, Inc.
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Fuji Capsules Co., Ltd.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. Procaps
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. NOW Foods Inc.
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Thermo Fisher Scientific, Inc. (Patheon)
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Sirio Pharma Co., LTD
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Super Spectrim
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.)
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Enteric Soft Gel Capsules Market Drivers & Restraints 2021
Table 7. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 8. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Enteric Soft Gel Capsules Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Enteric Soft Gel Capsules Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 138. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 139. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 140. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 141. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 142. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 143. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 144. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 145. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 146. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 147. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 148. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 149. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 150. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 151. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 152. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 153. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 154. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 155. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 156. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 157. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 158. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 159. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 160. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 161. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 162. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 163. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Leading 10 Enteric Soft Gel Capsules Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 313. BASF SE Profile 2019 (CEO, HQ, Founded, Website)
Table 314. BASF SE Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 315. Catalent, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 316. Catalent, Inc. Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 317. Colorcon, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 318. Colorcon, Inc. Enteric Soft Gel Capsules Product Offering (Segment, Product Offerings)
Table 319. Fuji Capsules Co., Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 320. Fuji Capsules Co., Ltd. Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 321. Procaps Profile 2019 (CEO, HQ, Founded, Website)
Table 322. Procaps Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 323. NOW Foods Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 324. NOW Foods Inc. Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 325. Thermo Fisher Scientific, Inc. (Patheon) Profile 2019 (CEO, HQ, Founded, Website)
Table 326. Thermo Fisher Scientific, Inc. (Patheon) Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 327. Super Spectrim Profile 2019 (CEO, HQ, Founded, Website)
Table 328. Super Spectrim Drugs of Abuse Product Offering (Segment, Product Offerings)
Table 329. Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.) Profile 2019 (CEO, HQ, Founded, Website)
Table 330. Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.) Enteric Soft Gel Capsules Product Offering (Segment, Product Offerings)
Table 331. Sirio Pharma Co., LTD Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 332. Sirio Pharma Co., LTD Enteric Soft Gel Capsules Product Offering (Segment, Product Offerings)
Table 333. Other Companies Involved in the Enteric Soft Gel Capsules Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Enteric Soft Gel Capsules Market Drivers & Restraints 2021
Figure 7. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 8. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Non-Gelatin Enteric Soft Gel Capsules Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Enteric Soft Gel Capsules Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Enteric Soft Gel Capsules Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Medical and Health Supplements Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Adult Patient Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Hospital Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Retail Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 98. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. North America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 103. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. North America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 108. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. North America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 113. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. North America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 118. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. North America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 123. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. North America Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. US Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Canada Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 138. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 139. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 140. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 141. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 142. Europe Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 143. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 144. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 145. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 146. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 147. Europe Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 148. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 149. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 150. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 151. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 152. Europe Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 153. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 154. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 155. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 156. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 157. Europe Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 158. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 159. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 160. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 161. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 162. Europe Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 163. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Europe Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. UK Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Germany Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. France Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Rest of Europe Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Asia Pacific Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 213. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 214. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 215. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 216. Asia Pacific Enteric Soft Gel Capsules Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 217. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 218. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 219. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 220. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 221. China Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 222. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 223. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 224. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 225. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 226. India Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 227. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 228. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 229. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 230. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 231. Japan Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 232. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 233. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 234. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 235. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 236. RoAPAC Enteric Soft Gel Capsules Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 237. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 238. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 239. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 240. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 241. Middle East Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 242. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 243. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 244. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 245. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 246. Middle East Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 247. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 248. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 249. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 250. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 251. Middle East Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 252. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 253. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 254. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 255. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 256. Middle East Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 257. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 258. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 259. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 260. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 261. Middle East Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 262. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 263. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 264. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 265. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 266. Latin America Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 267. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 268. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 269. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 270. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 271. Latin America Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 272. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 273. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 274. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 275. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 276. Latin America Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 277. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 278. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 279. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 280. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 281. Latin America Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 282. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 283. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 284. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 285. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 286. Latin America Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 287. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 288. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 289. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 290. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 291. Africa Enteric Soft Gel Capsules Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 292. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 293. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 294. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 295. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 296. Africa Enteric Soft Gel Capsules Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 297. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 298. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 299. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 300. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 301. Africa Enteric Soft Gel Capsules Market Forecast By Age Group 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 302. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 303. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 304. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 305. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 306. Africa Enteric Soft Gel Capsules Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 307. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 308. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 309. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 310. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 311. Africa Enteric Soft Gel Capsules Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 312. Porter’s Five Force Analysis
Companies Mentioned
1. Abbott Laboratories
2. AbbVie
3. Achaogen
4. Actavis
5. Actelion
6. Affinium Pharmaceutical
7. AiCuris GmbH & Co. KG
8. Alcon
9. Alkem Laboratories
10. Allergan
11. Allied Pharma
12. Apotex
13. APP Pharmaceuticals
14. Aptalis Pharma
15. Aquapharm Biodiscovery
16. Cempra Pharmaceuticals
17. Cipla
18. Claris Lifesciences
19. Cornerstone Biopharma
20. Cornerstone Therapeutics
21. Corona Remedies
22. Eli Lilly
23. Gate Pharma
24. Gilead Sciences
25. GlaxoSmithKline (GSK)
26. Glenmark
27. GlycoVaxyn
28. Hetero
29. Hikma Farmaceutica
30. Hi-Tech Pharma
31. Hospira
32. Macleod Pharmaceuticals
33. Microlabs
34. Nalneva
35. Novartis
36. Novexel
37. Paratek Pharmaceuticals
38. Pfizer
39. Ranbaxy
40. Roche
41. Sagent Pharmaceuticals
42. Sandoz
43. Sanofi
44. Sequella
45. Shanghai MengKe Pharmaceuticals
46. Shionogi
47. SHIONOGI Co., Ltd.
48. Shire
49. Sidmak Labs
50. Solitaire Pharmacia
51. Specialised Therapeutics Australia
Companies Profiled in the Report
1. BASF SE
2. Catalent, Inc.
3. Colorcon, Inc.
4. Fuji Capsules Co., Ltd.
5. Procaps
6. NOW Foods Inc.
7. Thermo Fisher Scientific, Inc. (Patheon)
8. Sirio Pharma Co., LTD
9. Super Spectrim
10. Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.)
List of Companies Mentioned in the Report:
1. Abbott Laboratories
2. AbbVie
3. Achaogen
4. Actavis
5. Actelion
6. Affinium Pharmaceutical
7. AiCuris GmbH & Co. KG
8. Alcon
9. Alkem Laboratories
10. Allergan
11. Allied Pharma
12. Apotex
13. APP Pharmaceuticals
14. Aptalis Pharma
15. Aquapharm Biodiscovery
16. Cempra Pharmaceuticals
17. Cipla
18. Claris Lifesciences
19. Cornerstone Biopharma
20. Cornerstone Therapeutics
21. Corona Remedies
22. Eli Lilly
23. Gate Pharma
24. Gilead Sciences
25. GlaxoSmithKline (GSK)
26. Glenmark
27. GlycoVaxyn
28. Hetero
29. Hikma Farmaceutica
30. Hi-Tech Pharma
31. Hospira
32. Macleod Pharmaceuticals
33. Microlabs
34. Nalneva
35. Novartis
36. Novexel
37. Paratek Pharmaceuticals
38. Pfizer
39. Ranbaxy
40. Roche
41. Sagent Pharmaceuticals
42. Sandoz
43. Sanofi
44. Sequella
45. Shanghai MengKe Pharmaceuticals
46. Shionogi
47. SHIONOGI Co., Ltd.
48. Shire
49. Sidmak Labs
50. Solitaire Pharmacia
51. Specialised Therapeutics Australia
List of Organizations Mentioned in the Report:
1. European Medicines Agency (EMA)
2. Food and Drug Administration (FDA)
3. National Institutes of Health (NIH)
4. University of Connecticut
5. World Health Organization (WHO)
6. The National Medical Products Administration (NMPA)
7. Indian Council of Medical Research (ICMR)
8. The Therapeutic Goods Administration
9. The Federal Institute for Drugs and Medical Devices (BfArM)
10. Pharmaceuticals and Medical Devices Agency (PMDA)
11. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
12. Ministry of Health, Labour & Welfare(MHLW)
13. Medicines and Healthcare Products Regulatory Agency (MHRA)
14. Centre for Pharmaceutical Administration Health Sciences Authority
15. Central Drug Standard Control Organization (CDSCO)
16. Organisation for Economic Co-operation and Development (OECD)
17. United Nations (UN)
18. United Nations Office on Drugs and Crime (UNODC)
19. United Nations Statistics Division (UNSD)
20. Statistical Office of the European Union (EUROSTAT)
1. BASF SE
2. Catalent, Inc.
3. Colorcon, Inc.
4. Fuji Capsules Co., Ltd.
5. Procaps
6. NOW Foods Inc.
7. Thermo Fisher Scientific, Inc. (Patheon)
8. Sirio Pharma Co., LTD
9. Super Spectrim
10. Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.)
List of Companies Mentioned in the Report:
1. Abbott Laboratories
2. AbbVie
3. Achaogen
4. Actavis
5. Actelion
6. Affinium Pharmaceutical
7. AiCuris GmbH & Co. KG
8. Alcon
9. Alkem Laboratories
10. Allergan
11. Allied Pharma
12. Apotex
13. APP Pharmaceuticals
14. Aptalis Pharma
15. Aquapharm Biodiscovery
16. Cempra Pharmaceuticals
17. Cipla
18. Claris Lifesciences
19. Cornerstone Biopharma
20. Cornerstone Therapeutics
21. Corona Remedies
22. Eli Lilly
23. Gate Pharma
24. Gilead Sciences
25. GlaxoSmithKline (GSK)
26. Glenmark
27. GlycoVaxyn
28. Hetero
29. Hikma Farmaceutica
30. Hi-Tech Pharma
31. Hospira
32. Macleod Pharmaceuticals
33. Microlabs
34. Nalneva
35. Novartis
36. Novexel
37. Paratek Pharmaceuticals
38. Pfizer
39. Ranbaxy
40. Roche
41. Sagent Pharmaceuticals
42. Sandoz
43. Sanofi
44. Sequella
45. Shanghai MengKe Pharmaceuticals
46. Shionogi
47. SHIONOGI Co., Ltd.
48. Shire
49. Sidmak Labs
50. Solitaire Pharmacia
51. Specialised Therapeutics Australia
List of Organizations Mentioned in the Report:
1. European Medicines Agency (EMA)
2. Food and Drug Administration (FDA)
3. National Institutes of Health (NIH)
4. University of Connecticut
5. World Health Organization (WHO)
6. The National Medical Products Administration (NMPA)
7. Indian Council of Medical Research (ICMR)
8. The Therapeutic Goods Administration
9. The Federal Institute for Drugs and Medical Devices (BfArM)
10. Pharmaceuticals and Medical Devices Agency (PMDA)
11. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
12. Ministry of Health, Labour & Welfare(MHLW)
13. Medicines and Healthcare Products Regulatory Agency (MHRA)
14. Centre for Pharmaceutical Administration Health Sciences Authority
15. Central Drug Standard Control Organization (CDSCO)
16. Organisation for Economic Co-operation and Development (OECD)
17. United Nations (UN)
18. United Nations Office on Drugs and Crime (UNODC)
19. United Nations Statistics Division (UNSD)
20. Statistical Office of the European Union (EUROSTAT)
Download sample pages
Complete the form below to download your free sample pages for Enteric Soft Gel Capsules Market Report 2021-2031Related reports
-
Therapeutic Respiratory Devices Market Report 2021-2031
The worldwide demand for therapeutic respiratory devices market is anticipated to grow on account of rising burden of respiratory diseases,...Full DetailsPublished: 26 April 2021 -
Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power,...Full DetailsPublished: 31 March 2021 -
Antibody Drug Conjugates Market Report 2021-2031
Antibody drug conjugate (ADC) technology continues to evolve as a widely successful drug targeting technology for the treatment of cancer....
Full DetailsPublished: 03 November 2020 -
Anti-Infective Agents Market Report 2021-2031
Rising incidences of infectious diseases is one of the prime factors driving the growth of the global anti-infective agents market...Full DetailsPublished: 11 May 2021 -
Aortic Aneurysm Market Report 2021-2031
The growth in the market can be attributed to the high tobacco smoking prevalence in the developed and developing region,...Full DetailsPublished: 21 April 2021 -
Antibiotics Market Report 2021-2031
The rising prevalence of tuberculosis, malaria, pneumonia, bacterial skin infections, HIV/AIDS, urinary tract infections (UTI), and other diseases will support...Full DetailsPublished: 15 April 2021 -
Cancer Diagnostics Market Report 2021-2031
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel...Full DetailsPublished: 14 April 2021 -
Antiviral Drugs Treatment Market Report 2021-2031
Rising incidences of viral infection; increasing geriatric population is projected to propel the demand for anti-viral drugs; advancement in anti-viral...Full DetailsPublished: 26 April 2021 -
Cell-Based Assays Market Report to 2030
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are...Full DetailsPublished: 04 March 2021 -
Preclinical CRO Market Report 2020-2030
The increase in number of drugs in preclinical phase, increase in R&D investments, need to contain expenses for drug discovery...
Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Enteric Soft Gel Capsules Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034
The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.
11 April 2024
